Blog

Why Use Standardized Kits When Differentiating Pluripotent Stem Cells

Thursday, February 23, 2017 - 13:35

Standardized pluripotent stem cell differentiation kits, such as the StemXVivo® Differentiation Kits from R&D Systems, offer a number of benefits over both home-brew protocols or the direct purchase of pre-differentiated iPS cells. This post provides a brief discussion of those benefits:

Consistent Method for Assessing Pluripotency – Researchers creating iPS cell lines must verify the pluripotency of their newly generated cells. The teratoma assay and the embryoid body assay are the historical standard for validation. However, they are time consuming and inconsistent. Differentiation kits are ideal for applying a fast and standardized method to pluripotency validation because they...

Bio-Techne Go Everywhere Travel Grant – January Recipient Selected!

Monday, February 13, 2017 - 10:53

Bio-Techne continues to support the work of researchers worldwide with travel grants awarded to specific conferences throughout the year. In 2017, we launched our Go Everywhere Travel Grant Program which awards 1 researcher each month in 2017 with a $1000 USD (or equivalent) travel grant to attend the meeting of their choice. This allows the researchers to attend more targeted meetings in their field and provides funding to support both small and large associations to further promote scientific discoveries and conversations.

The first recipient of 2017 is Dr. Olalekan Ogundele from Louisiana State University!

...

Xeno-free, Serum-free, What’s for me? - Mesenchymal Stem Cell Media

Wednesday, February 1, 2017 - 07:46

Mesenchymal stem cells (MSC) hold significant promise for tissue engineering and regenerative medicine. While the use of MSCs for both translational and basic research requires their efficient expansion, the desired media formulations for growing MSCs can vary by application. Specific formulations of MSC media now exist to address these various applications, including serum-containing, serum-free, xeno-free, and GMP-grade media. For many researchers, deciphering which variant of MSC media best suits their needs can be a daunting prospect. This post is meant to help clarify MSC media nomenclature and provide a quick reference for understanding the various media options and when to use them in your research.

MSC Media...

Bio-Techne's Karen Padgett Awarded Lifetime Achievement Award from CiteAb

Tuesday, January 31, 2017 - 15:22

Karen Padgett Awarded Lifetime Achievement Award CiteAb

Each year, CiteAb recognizes several companies and individuals for their excellence in the research antibody market. This year, the Lifetime Achievement Award has been awarded to Bio-Techne’s own, Karen Padgett. Join us in congratulating her for her dedication and drive she brings to this business.

Karen started Novus Biologicals in the summer of 1996 to be a company that licenses, produces and markets antibodies for niche and emerging areas of research. She successfully ran Novus Biologicals with consistent growth for 18 years out of Littleton, CO. She sold Novus

...

R&D Systems® Immunoassays and Luminex® Instruments Video

Thursday, November 10, 2016 - 08:54

This video describes the strengths of R&D Systems immunoassays and the effective partnership with Luminex to answer your multianalyte questions.

What does Bio-Techne Bring to Regenerative Medicine?

Tuesday, October 18, 2016 - 12:57

The use of stem cells for regenerative medicine and cell therapy is closer than ever to therapeutic application. As researchers navigate their stem cell research into the translational landscape, maintaining quality and consistency becomes an important issue. That’s where Bio-Techne can help. Bio-Techne, consisting of the prestigious life science brands of R&D SystemsNovus BiologicalsTocris Bioscience, takes pride in its roots as a company devoted to reagent quality and consistency. Because we offer both research and GMP-grade reagents, we can be a resource to researchers and biopharmaceutical companies as they think about out how they are...

5 Tips to Increase the Reproducibility of MSC and iPSC Differentiation

Tuesday, October 11, 2016 - 13:50

Mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) are being utilized for the development of multitude of regenerative therapies. Establishing standards and practices for characterizing MSCs and iPSCs is an important quality issue for the future of stem cell research and regenerative medicine. Simple steps can be taken to improve the quality and efficiency of both MSC and iPSC expansion and differentiation.

Check out this article we wrote on Regmednet that provides 5 tips that could get you the quality and quantity of cells that you desire.

Learn More about Top Researchers with Our New Interview Series

Wednesday, August 24, 2016 - 03:51

Novus Biologicals is launching an interview series to learn more about the research being done by leaders in a variety of research areas. We also ask what drives these faculty members to do research and why they think their research is important to the general public. Look forward to a new interview each month!

Our first interview features Noboru Mizushima, Professor of Biochemistry and Molecular Biology at the University of Tokyo. Dr. Mizushima has made many critical findings in the field of autophagy and is one of the most highly cited researchers in his field. Learn more about Dr. Mizushima and find out what he had to say about his research and where he sees it moving in the future.

Blog Categories


Archives